Darbepoetin-α treatment enhances glomerular regenerative process in the Thy-1 glomerulonephritis model

American Journal of Physiology - Renal Physiology

Volumn 299, Issue 6, 2010, Pages

  Cañadillas López, Sagrario ^a   Ortega, Rosa ^a   Estepa, Jose Carlos ^a   Egea, Jeronimo ^a   Gonzalez Menchen, Alberto ^a   Perez Seoane, Carlos ^a   Lopez Andreu, Maria ^c   Ramirez, Rafael ^a   Tetta, Ciro ^b   Rodriguez, Mariano ^a,c   Martin Malo, Alejandro ^c   Aljama, Pedro ^c  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b FRESENIUS MEDICAL CARE   (Germany)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Cytoprotective effects; Erythropoietin analog; Glomerular regeneration

Indexed keywords

ALPHA ACTIN; CASPASE 3; CREATININE; DESMIN; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; THY 1 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; ELECTRON MICROSCOPY; GLOMERULONEPHRITIS; GLOMERULUS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; MALE; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; REPEATED DRUG DOSE; TISSUE REGENERATION;

EID: 78649926915     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00343.2009     Document Type: Article

References (28)

1. Bagchus WM, Hoedemaeker PJ, Rozing J, Bakker WW. Glomerulonephritis induced by monoclonal anti-Thy 1.1 antibodies. A sequential histological and ultrastructural study in the rat. Lab Invest 55: 680-687, 1986.
2. Bahlmann FH, DeGroot K, Duckert Niemczyk ET, Bahlmann E, Boehm SM, Haller H, Fliser D. Endothelial progenitor cell proliferation, and differentiation is regulated by erythropoietin. Kidney Int 64: 1648-1652, 2003.
3. Bahlmann FH, Song R, Boehm Mengel M SM, von Wasielewski R, Lindschau C, Kirsch T, de Groot K, Laudeley R, Niemczyk E, Güler F, Menne J, Haller H, Fliser D. Low-dose therapy with the long acting erythropoietin analogue darbepoetin-α alpha persistently activates endothelial Akt, and attenuates progressive organ failure. Circulation 110: 1006-1012, 2004.
4. Bahlmann FH, Kielstein JT, Haller H, Fliser D. Erythropoietin and progression of CKD. Kidney Int Suppl 107: S21-S25, 2007.
5. Brines M, Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 6: 484-494, 2005. (Pubitemid 40769173)
6. Chatterjee PK. Pleiotropic renal actions of erythropoietin. Lancet 365: 1890-1892, 2005.
7. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. Akt phosphorylation of BAD couples survival signals to the cellintrinsic death machinery. Cell 91: 231-41, 1997.
8. Eto N, Wada T, Inagi R, Shimizu A, Kato H, Kurihara H, Kawachi H, Shankland SJ, Fujita T, Nangaku M.Podocyte protection by darbepoetin-α: preservation of the cytoskeleton, and nephrin expression. Kidney Int 72: 455-463, 2007.
9. Fliser D, Haller H. Erythropoietin, and treatment of non-anaemic conditions- cardiovascular protection. Semin Hematol 44: 212-217, 2007.
10. Hugo C, Shankland SJ, Bowen-Pope DF, Couser WG, Johnson RJ. Extraglomerular origin of the mesangial cell after injury. A new role of the juxtaglomerular apparatus. J Clin Invest 100: 786-794, 1997.
11. Iruela-Arispe L, Gordon K, Hugo C, Duijvestijn AM, Claffey KP, Reilly M, Couser WG, Alpers CE, Johnson RJ. Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am J Pathol 147: 1715-1727, 1995.
12. Jefferson JA, Johnson RJ. Experimental mesangial proliferative glomerulonephritis (the anti-Thy-1.1 model). J Nephrol 12: 297-307, 1999.
13. Johnson DW, Forman C, Vesey DA. Novel renoprotective actions of erythropoietin: new uses for an old hormone. Nephrology 11: 306-312 2006.
14. Joyeux-Faure M, Godin-Ribuot D, Ribuot C. Erythropoietin and myocardial protection: what's new? Fundam Clin Pharmacol 19: 439-46, 2005.
15. Kazutomo Sawai Kiyoshi Mori Masashi Mukoyama Suganami T, Koshikawa M, Yahata K, Makino H, Nagae T, Fujinaga Y, Yokoi H, Yoshioka T, Yoshimoto A, Tanaka I, Nakao K. Angiogenic protein Cyr61 is expressed by podocytes in anti-Thy-1 glomerulonephritis. J Am Soc Nephrol 14: 1154-1163, 2003. (Pubitemid 36514658)
16. Li F, Chong ZZ, Maiese K. Erythropoietin on a tightrope: balancing neuronal, and vascular protection between intrinsic and extrinsic pathways. Neurosignals 13: 265-289, 2004.
17. Logar CM, Brinkkoetter PT, Krofft RD, Pippin JW, Shankland SJ. Darbepoetin alfa protects podocytes from apoptosis in vitro, and in vivo. Kidney Int 72: 489-498, 2007.
18. Morishita E, Narita H, Nishida M, Kawashima N, Yamagishi K, Masuda S, Nagao M, Hatta H, Sasaki R. Anti-erythropoietin receptor monoclonal antibody: epitope mapping, quantification of the soluble receptor, and detection of the solubilized transmembrane receptor and the receptor-expressing cells. Blood 88: 465-4471, 1996.
19. Morita T, Churg J. Mesangiolysis. Kidney Int 24: 1-9, 1983.
20. Paul LC, Rennke HG, Milford EL, Carpenter CB. Thy-1.1 in glomeruli of rat kidneys. Kidney Int 25: 771-777, 1984.
21. Rennke HG, Anderson S, Brenner BM. The progression of renal disease: Structural, and functional correlations. In: Renal Pathology, edited by Tisher CC and Brenner BM. Philadelphia, PA: Lippincott, 1994, p 116.
22. Sharples EJ, Yaqoob MM. Erythropoietin in experimental acute renal failure. Nephron Exp Nephrol 104: 83-88, 2006.
23. Socolovsky M, Fallon AE, Wang S, Brugnara C, Lodish HF. Fetal anemia, and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-XL induction. Cell 98: 181-191, 1999.
24. Tramontano AF, Muniyappa R, Black AD, Blendea MC, Cohen I, Deng L, Sowers JR, Cutaia MV, El-Sherif N. Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway. Biochem Biophys Res Commun 308: 990-994, 2003. (Pubitemid 36976556)
25. Um M, Lodish HF. Antiapoptotic effects of erythropoietin in differentiated neuroblastoma SH-SY5Y cells require activation of both the STAT5 and AKT signalling pathways. J Biol Chem 281: 5648-5656, 2006.
26. Um M, Gross AW, Lodish HF. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells. Cell Signal 19: 634-645, 2007.
27. Westenfelder C, Biddle DL, Baranowski RL. Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int 55: 808-820, 1999.
28. Zhang L, Nakazawa K, Shigematsu H. Participation of endothelial cells, and transformed mesangial cells in remodelling of glomerular capillary loops in Thy-1 nephritis. Pathol Int 51: 227-239, 2001.